The global market for Intravenous Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Intravenous Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Intravenous Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Intravenous Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Intravenous Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Intravenous Treatment players cover ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.) and Amanta Healthcare (India), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Intravenous Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Intravenous Treatment market, with both quantitative and qualitative data, to help readers understand how the Intravenous Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Intravenous Treatment market and forecasts the market size by Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition,), by Application (Hospitals and Clinics, Outpatient clinic and Home Care,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segmentation by application
Hospitals and Clinics
Outpatient clinic
Home Care
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
Chapter Introduction
Chapter 1: Scope of Intravenous Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Intravenous Treatment market size (sales and revenue) and CAGR, Intravenous Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Intravenous Treatment sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Intravenous Treatment sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Intravenous Treatment market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including ICU Medical Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo) and Grifols S.A. (Spain), etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intravenous Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intravenous Treatment by Country/Region, 2017, 2022 & 2028
2.2 Intravenous Treatment Segment by Type
2.2.1 Peripheral Parenteral Nutrition
2.2.2 Total Parenteral Nutrition
2.3 Intravenous Treatment Sales by Type
2.3.1 Global Intravenous Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Intravenous Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intravenous Treatment Sale Price by Type (2017-2022)
2.4 Intravenous Treatment Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Outpatient clinic
2.4.3 Home Care
2.5 Intravenous Treatment Sales by Application
2.5.1 Global Intravenous Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Intravenous Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intravenous Treatment Sale Price by Application (2017-2022)
3 Global Intravenous Treatment by Company
3.1 Global Intravenous Treatment Breakdown Data by Company
3.1.1 Global Intravenous Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Intravenous Treatment Sales Market Share by Company (2020-2022)
3.2 Global Intravenous Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Intravenous Treatment Revenue by Company (2020-2022)
3.2.2 Global Intravenous Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Intravenous Treatment Sale Price by Company
3.4 Key Manufacturers Intravenous Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Treatment Product Location Distribution
3.4.2 Players Intravenous Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intravenous Treatment by Geographic Region
4.1 World Historic Intravenous Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Intravenous Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intravenous Treatment Annual Revenue by Geographic Region
4.2 World Historic Intravenous Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Intravenous Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intravenous Treatment Annual Revenue by Country/Region
4.3 Americas Intravenous Treatment Sales Growth
4.4 APAC Intravenous Treatment Sales Growth
4.5 Europe Intravenous Treatment Sales Growth
4.6 Middle East & Africa Intravenous Treatment Sales Growth
5 Americas
5.1 Americas Intravenous Treatment Sales by Country
5.1.1 Americas Intravenous Treatment Sales by Country (2017-2022)
5.1.2 Americas Intravenous Treatment Revenue by Country (2017-2022)
5.2 Americas Intravenous Treatment Sales by Type
5.3 Americas Intravenous Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Treatment Sales by Region
6.1.1 APAC Intravenous Treatment Sales by Region (2017-2022)
6.1.2 APAC Intravenous Treatment Revenue by Region (2017-2022)
6.2 APAC Intravenous Treatment Sales by Type
6.3 APAC Intravenous Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intravenous Treatment by Country
7.1.1 Europe Intravenous Treatment Sales by Country (2017-2022)
7.1.2 Europe Intravenous Treatment Revenue by Country (2017-2022)
7.2 Europe Intravenous Treatment Sales by Type
7.3 Europe Intravenous Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Treatment by Country
8.1.1 Middle East & Africa Intravenous Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intravenous Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Intravenous Treatment Sales by Type
8.3 Middle East & Africa Intravenous Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Treatment
10.3 Manufacturing Process Analysis of Intravenous Treatment
10.4 Industry Chain Structure of Intravenous Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Treatment Distributors
11.3 Intravenous Treatment Customer
12 World Forecast Review for Intravenous Treatment by Geographic Region
12.1 Global Intravenous Treatment Market Size Forecast by Region
12.1.1 Global Intravenous Treatment Forecast by Region (2023-2028)
12.1.2 Global Intravenous Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous Treatment Forecast by Type
12.7 Global Intravenous Treatment Forecast by Application
13 Key Players Analysis
13.1 ICU Medical Inc. (U.S.)
13.1.1 ICU Medical Inc. (U.S.) Company Information
13.1.2 ICU Medical Inc. (U.S.) Intravenous Treatment Product Offered
13.1.3 ICU Medical Inc. (U.S.) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ICU Medical Inc. (U.S.) Main Business Overview
13.1.5 ICU Medical Inc. (U.S.) Latest Developments
13.2 B. Braun Melsungen AG (Germany)
13.2.1 B. Braun Melsungen AG (Germany) Company Information
13.2.2 B. Braun Melsungen AG (Germany) Intravenous Treatment Product Offered
13.2.3 B. Braun Melsungen AG (Germany) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 B. Braun Melsungen AG (Germany) Main Business Overview
13.2.5 B. Braun Melsungen AG (Germany) Latest Developments
13.3 Fresenius Kabi AG (Germany)
13.3.1 Fresenius Kabi AG (Germany) Company Information
13.3.2 Fresenius Kabi AG (Germany) Intravenous Treatment Product Offered
13.3.3 Fresenius Kabi AG (Germany) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Fresenius Kabi AG (Germany) Main Business Overview
13.3.5 Fresenius Kabi AG (Germany) Latest Developments
13.4 Baxter (U.S.)
13.4.1 Baxter (U.S.) Company Information
13.4.2 Baxter (U.S.) Intravenous Treatment Product Offered
13.4.3 Baxter (U.S.) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Baxter (U.S.) Main Business Overview
13.4.5 Baxter (U.S.) Latest Developments
13.5 Amanta Healthcare (India)
13.5.1 Amanta Healthcare (India) Company Information
13.5.2 Amanta Healthcare (India) Intravenous Treatment Product Offered
13.5.3 Amanta Healthcare (India) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Amanta Healthcare (India) Main Business Overview
13.5.5 Amanta Healthcare (India) Latest Developments
13.6 Terumo Medical Corporation (Tokyo)
13.6.1 Terumo Medical Corporation (Tokyo) Company Information
13.6.2 Terumo Medical Corporation (Tokyo) Intravenous Treatment Product Offered
13.6.3 Terumo Medical Corporation (Tokyo) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Terumo Medical Corporation (Tokyo) Main Business Overview
13.6.5 Terumo Medical Corporation (Tokyo) Latest Developments
13.7 Grifols S.A. (Spain)
13.7.1 Grifols S.A. (Spain) Company Information
13.7.2 Grifols S.A. (Spain) Intravenous Treatment Product Offered
13.7.3 Grifols S.A. (Spain) Intravenous Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Grifols S.A. (Spain) Main Business Overview
13.7.5 Grifols S.A. (Spain) Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Intravenous Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intravenous Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Peripheral Parenteral Nutrition
Table 4. Major Players of Total Parenteral Nutrition
Table 5. Global Intravenous Treatment Sales by Type (2017-2022) & (K Units)
Table 6. Global Intravenous Treatment Sales Market Share by Type (2017-2022)
Table 7. Global Intravenous Treatment Revenue by Type (2017-2022) & ($ million)
Table 8. Global Intravenous Treatment Revenue Market Share by Type (2017-2022)
Table 9. Global Intravenous Treatment Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Intravenous Treatment Sales by Application (2017-2022) & (K Units)
Table 11. Global Intravenous Treatment Sales Market Share by Application (2017-2022)
Table 12. Global Intravenous Treatment Revenue by Application (2017-2022)
Table 13. Global Intravenous Treatment Revenue Market Share by Application (2017-2022)
Table 14. Global Intravenous Treatment Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Intravenous Treatment Sales by Company (2020-2022) & (K Units)
Table 16. Global Intravenous Treatment Sales Market Share by Company (2020-2022)
Table 17. Global Intravenous Treatment Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Intravenous Treatment Revenue Market Share by Company (2020-2022)
Table 19. Global Intravenous Treatment Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Intravenous Treatment Producing Area Distribution and Sales Area
Table 21. Players Intravenous Treatment Products Offered
Table 22. Intravenous Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Intravenous Treatment Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Intravenous Treatment Sales Market Share Geographic Region (2017-2022)
Table 27. Global Intravenous Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Intravenous Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Intravenous Treatment Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Intravenous Treatment Sales Market Share by Country/Region (2017-2022)
Table 31. Global Intravenous Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Intravenous Treatment Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Intravenous Treatment Sales by Country (2017-2022) & (K Units)
Table 34. Americas Intravenous Treatment Sales Market Share by Country (2017-2022)
Table 35. Americas Intravenous Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Intravenous Treatment Revenue Market Share by Country (2017-2022)
Table 37. Americas Intravenous Treatment Sales by Type (2017-2022) & (K Units)
Table 38. Americas Intravenous Treatment Sales Market Share by Type (2017-2022)
Table 39. Americas Intravenous Treatment Sales by Application (2017-2022) & (K Units)
Table 40. Americas Intravenous Treatment Sales Market Share by Application (2017-2022)
Table 41. APAC Intravenous Treatment Sales by Region (2017-2022) & (K Units)
Table 42. APAC Intravenous Treatment Sales Market Share by Region (2017-2022)
Table 43. APAC Intravenous Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Intravenous Treatment Revenue Market Share by Region (2017-2022)
Table 45. APAC Intravenous Treatment Sales by Type (2017-2022) & (K Units)
Table 46. APAC Intravenous Treatment Sales Market Share by Type (2017-2022)
Table 47. APAC Intravenous Treatment Sales by Application (2017-2022) & (K Units)
Table 48. APAC Intravenous Treatment Sales Market Share by Application (2017-2022)
Table 49. Europe Intravenous Treatment Sales by Country (2017-2022) & (K Units)
Table 50. Europe Intravenous Treatment Sales Market Share by Country (2017-2022)
Table 51. Europe Intravenous Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Intravenous Treatment Revenue Market Share by Country (2017-2022)
Table 53. Europe Intravenous Treatment Sales by Type (2017-2022) & (K Units)
Table 54. Europe Intravenous Treatment Sales Market Share by Type (2017-2022)
Table 55. Europe Intravenous Treatment Sales by Application (2017-2022) & (K Units)
Table 56. Europe Intravenous Treatment Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Intravenous Treatment Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Intravenous Treatment Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Intravenous Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Intravenous Treatment Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Intravenous Treatment Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Intravenous Treatment Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Intravenous Treatment Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Intravenous Treatment Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Intravenous Treatment
Table 66. Key Market Challenges & Risks of Intravenous Treatment
Table 67. Key Industry Trends of Intravenous Treatment
Table 68. Intravenous Treatment Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Intravenous Treatment Distributors List
Table 71. Intravenous Treatment Customer List
Table 72. Global Intravenous Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Intravenous Treatment Sales Market Forecast by Region
Table 74. Global Intravenous Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Intravenous Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Intravenous Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Intravenous Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Intravenous Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Intravenous Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Intravenous Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Intravenous Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Intravenous Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Intravenous Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Intravenous Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Intravenous Treatment Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Intravenous Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Intravenous Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Intravenous Treatment Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Intravenous Treatment Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Intravenous Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Intravenous Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 92. ICU Medical Inc. (U.S.) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 93. ICU Medical Inc. (U.S.) Intravenous Treatment Product Offered
Table 94. ICU Medical Inc. (U.S.) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. ICU Medical Inc. (U.S.) Main Business
Table 96. ICU Medical Inc. (U.S.) Latest Developments
Table 97. B. Braun Melsungen AG (Germany) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 98. B. Braun Melsungen AG (Germany) Intravenous Treatment Product Offered
Table 99. B. Braun Melsungen AG (Germany) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. B. Braun Melsungen AG (Germany) Main Business
Table 101. B. Braun Melsungen AG (Germany) Latest Developments
Table 102. Fresenius Kabi AG (Germany) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 103. Fresenius Kabi AG (Germany) Intravenous Treatment Product Offered
Table 104. Fresenius Kabi AG (Germany) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Fresenius Kabi AG (Germany) Main Business
Table 106. Fresenius Kabi AG (Germany) Latest Developments
Table 107. Baxter (U.S.) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 108. Baxter (U.S.) Intravenous Treatment Product Offered
Table 109. Baxter (U.S.) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Baxter (U.S.) Main Business
Table 111. Baxter (U.S.) Latest Developments
Table 112. Amanta Healthcare (India) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 113. Amanta Healthcare (India) Intravenous Treatment Product Offered
Table 114. Amanta Healthcare (India) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Amanta Healthcare (India) Main Business
Table 116. Amanta Healthcare (India) Latest Developments
Table 117. Terumo Medical Corporation (Tokyo) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 118. Terumo Medical Corporation (Tokyo) Intravenous Treatment Product Offered
Table 119. Terumo Medical Corporation (Tokyo) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Terumo Medical Corporation (Tokyo) Main Business
Table 121. Terumo Medical Corporation (Tokyo) Latest Developments
Table 122. Grifols S.A. (Spain) Basic Information, Intravenous Treatment Manufacturing Base, Sales Area and Its Competitors
Table 123. Grifols S.A. (Spain) Intravenous Treatment Product Offered
Table 124. Grifols S.A. (Spain) Intravenous Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Grifols S.A. (Spain) Main Business
Table 126. Grifols S.A. (Spain) Latest Developments
List of Figures
Figure 1. Picture of Intravenous Treatment
Figure 2. Intravenous Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Treatment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Intravenous Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intravenous Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Peripheral Parenteral Nutrition
Figure 10. Product Picture of Total Parenteral Nutrition
Figure 11. Global Intravenous Treatment Sales Market Share by Type in 2021
Figure 12. Global Intravenous Treatment Revenue Market Share by Type (2017-2022)
Figure 13. Intravenous Treatment Consumed in Hospitals and Clinics
Figure 14. Global Intravenous Treatment Market: Hospitals and Clinics (2017-2022) & (K Units)
Figure 15. Intravenous Treatment Consumed in Outpatient clinic
Figure 16. Global Intravenous Treatment Market: Outpatient clinic (2017-2022) & (K Units)
Figure 17. Intravenous Treatment Consumed in Home Care
Figure 18. Global Intravenous Treatment Market: Home Care (2017-2022) & (K Units)
Figure 19. Global Intravenous Treatment Sales Market Share by Application (2017-2022)
Figure 20. Global Intravenous Treatment Revenue Market Share by Application in 2021
Figure 21. Intravenous Treatment Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Intravenous Treatment Revenue Market Share by Company in 2021
Figure 23. Global Intravenous Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Intravenous Treatment Revenue Market Share by Geographic Region in 2021
Figure 25. Global Intravenous Treatment Sales Market Share by Region (2017-2022)
Figure 26. Global Intravenous Treatment Revenue Market Share by Country/Region in 2021
Figure 27. Americas Intravenous Treatment Sales 2017-2022 (K Units)
Figure 28. Americas Intravenous Treatment Revenue 2017-2022 ($ Millions)
Figure 29. APAC Intravenous Treatment Sales 2017-2022 (K Units)
Figure 30. APAC Intravenous Treatment Revenue 2017-2022 ($ Millions)
Figure 31. Europe Intravenous Treatment Sales 2017-2022 (K Units)
Figure 32. Europe Intravenous Treatment Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Intravenous Treatment Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Intravenous Treatment Revenue 2017-2022 ($ Millions)
Figure 35. Americas Intravenous Treatment Sales Market Share by Country in 2021
Figure 36. Americas Intravenous Treatment Revenue Market Share by Country in 2021
Figure 37. United States Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Intravenous Treatment Sales Market Share by Region in 2021
Figure 42. APAC Intravenous Treatment Revenue Market Share by Regions in 2021
Figure 43. China Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Intravenous Treatment Sales Market Share by Country in 2021
Figure 50. Europe Intravenous Treatment Revenue Market Share by Country in 2021
Figure 51. Germany Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Intravenous Treatment Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Intravenous Treatment Revenue Market Share by Country in 2021
Figure 58. Egypt Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Intravenous Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Intravenous Treatment in 2021
Figure 64. Manufacturing Process Analysis of Intravenous Treatment
Figure 65. Industry Chain Structure of Intravenous Treatment
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles